Research Details The study examined 193 patients with ovarian cancer treated at eight New York City hospitals. Just over 71 percent of the Black women with COVID-19 required hospitalization compared with 46 percent of non-Black patients. Of the 34 patients who died from COVID-19, 41.2 percent of them were Black.
Why It Matters The study analysis suggested that Black patients with COVID-19 had a higher prevalence of other health problems that contributed to their worsening COVID-19 infection. The underlying causes of racial disparities are multifactorial and include limited access to healthcare, [and] social determinants of health, racism, and discrimination. The COVID-19 pandemic has only heightened these and brought awareness, said senior author Bhavana Pothuri, MD, of NYU Langone Health in New York City.
Dec 29, 2020
MONDAY, Dec. 28, 2020 (HealthDay News) The incidence of young-onset esophageal adenocarcinoma is increasing, and patients present at more advanced stages compared with older patients, according to a study published online Dec. 11 in
Cancer Epidemiology, Biomarkers & Prevention.
Don C. Codipilly, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues queried the Surveillance, Epidemiology, and End Results 9 database to identify patients with esophageal adenocarcinoma between 1975 and 2015 to examine time trends in incidence and outcomes. Patients were stratified according to age: younger than 50, 50 to 69, and 70 years and older. Trends in incidence, disease stage, and survival were assessed for 1975 to 1989, 1990 to 1999, and 2000 to 2015.
Incidence of esophageal adenocarcinoma is increasing in younger adults
Bottom Line: Esophageal adenocarcinoma is occurring more frequently in adults under age 50, and these younger adults are more likely to be diagnosed at advanced stages.
Journal in Which the Study was Published: Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research
Author: Prasad G. Iyer, MD, MSc, professor of medicine in the Barrett s Esophagus Unit, Division of Gastroenterology and Hepatology; and Don C. Codipilly, MD, a gastroenterology fellow, both at the Mayo Clinic in Rochester, Minnesota.
Background: Esophageal cancer is a relatively rare cancer, with 18,440 cases expected to be diagnosed in the United States this year, according to the Surveillance, Epidemiology, and End Results (SEER) database. While those cases account for only about 1 percent of U.S. cancer diagnoses, esophageal cancer has poor survival outcomes, with a five-year survival rate of onl
More young adults are being diagnosed with esophageal adenocarcinoma
New research published in a journal of the American Association for Cancer Research,
Cancer Epidemiology, Biomarkers & Prevention, reports an increased incidence of esophageal adenocarcinoma in young adults under age 50, with young adults experiencing more diagnoses of advanced stages of the cancer.
Although cancer of the esophagus is not particularly common, esophageal adenocarcinoma (EAC) is one of the most common kinds of esophageal cancer. With a five-year survival rate of 19.9%, people with esophageal cancer have low survival outcomes. Patients who present with late-stage esophageal cancer typically have poorer outcomes than those with early-stage disease. As such, it is important to understand the epidemiology of esophageal cancer to target our screening strategies, explained Prasad G. Iyer, MD, MSc, who is a professor of medicine in the Barrett s Esophagus Unit at the Mayo Clinic in Rochester, Minnesot
Study shows rising incidence of esophageal adenocarcinoma in younger adults
Bottom Line: Esophageal adenocarcinoma is occurring more frequently in adults under age 50, and these younger adults are more likely to be diagnosed at advanced stages.
Journal in Which the Study was Published:
Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research
Author: Prasad G. Iyer, MD, MSc, professor of medicine in the Barrett s Esophagus Unit, Division of Gastroenterology and Hepatology; and Don C. Codipilly, MD, a gastroenterology fellow, both at the Mayo Clinic in Rochester, Minnesota.
Background: Esophageal cancer is a relatively rare cancer, with 18,440 cases expected to be diagnosed in the United States this year, according to the Surveillance, Epidemiology, and End Results (SEER) database. While those cases account for only about 1 percent of U.S. cancer diagnoses, esophageal cancer has poor survival outcomes, with a five-year survival rate